HOOKIPA PHARMA
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administere... d repeatedly, providing even greater immune protection. Levels of specific T cells generated by TheraT® are unprecedented in the field and have the potential to transform active immune-therapy in cancers. Hookipa has completed the active phase of a Phase 1 trial of a Vaxwave®-based vaccine against cytomegalovirus (CMV) and is finalizing clinical development plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.
HOOKIPA PHARMA
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2011-08-07
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.hookipapharma.com
Total Employee:
51+
Status:
Active
Contact:
+43 1 890 63 60
Total Funding:
224.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache IPv6 Yoast Plugins COVID-19 Apple Mobile Web App Capable
Similar Organizations
AC Immune
AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials
Aegle Therapeutics
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alentis Therapeutics
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Alethiomics
Alethiomics is a biotech company harnessing the power of single-cell multi-omic technology to discover & develop treatment for blood cancer.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alzheon
Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.
Atox Bio
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.
AudioCure Pharma
AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need.
Autifony Therapeutics
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
AYOXXA
AYOXXA is a biotech company commercializing innovative technology.
BioAegis Therapeutics
BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Camallergy
Camallergy develops and provides new treatments for common food allergies.
CinCor Pharma
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Connect Biopharmaceuticals
Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
CytunePharma
Cytune’s goal is to turn novel concepts into best-in class immunotherapeutics restoring and activating the immune system to fight cancer.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Eyevensys
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
Gadeta
Gadeta is a research and development company that develops immunotherapies for cancer.
Glycomine
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Hongyun Biotech
Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.
Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
Innoskel
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
Leyden Labs
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Medicortex Finland Oy
Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.
Mileutis
Mileutis is a clinical-stage company focused on developing and commercializing natural and novel peptides for animal and human health.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Oncopeptides
Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.
P-Cure
P-Cure is a biotech company has developed a patient centric proton therapy solution with clinical benefits and financial advantages.
PEP-Therapy
Innovative peptides as targeted therapies for oncology
Pepgen
PepGen is empowering nucleic acid therapeutics to go the distance.
Promethera Biosciences
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
Reapplix
Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.
Restore Vision
Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.
Bird Rock Bio
Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators.
StemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
Taiga Biotechnologies
Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Vasopharm
Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.
ZZ Biotech
A clinical stage company developing innovative biologic treatments for ischemic stroke.
Current Advisors List
Board_member
Board_member
Board_member
2022-01-01
Current Employees Featured
Lukas Flatz Founder @ Hookipa Pharma
Founder
Daniel Pinschewer Founder & Chief Scientific Officer @ Hookipa Pharma
Founder & Chief Scientific Officer
David Kaufman Director @ Hookipa Pharma
Director
2019-04-01
Christine D. Baker COO @ Hookipa Pharma
COO
2022-05-01
Rolf Zinkernagel Founder @ Hookipa Pharma
Founder
Andreas Bergthaler Founder @ Hookipa Pharma
Founder
Roman Necina Chief Development Officer (CDO) @ Hookipa Pharma
Chief Development Officer (CDO)
2022-01-01
Katia Schlienger EVP, Clinical Development @ Hookipa Pharma
EVP, Clinical Development
2022-01-01
Klaus Orlinger CSO @ Hookipa Pharma
CSO
2022-03-01
Reinhard Kandera Chief Financial Officer @ Hookipa Pharma
Chief Financial Officer
Founder
Stock Details
Investors List
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series D - Hookipa Pharma
Samsara BioCapital
Samsara BioCapital investment in Series D - Hookipa Pharma
Redmile Group
Redmile Group investment in Series D - Hookipa Pharma
Takeda Ventures
Takeda Ventures investment in Series D - Hookipa Pharma
Invus
Invus investment in Series D - Hookipa Pharma
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Hookipa Pharma
Takeda Ventures
Takeda Ventures investment in Series C - Hookipa Pharma
Sofinnova Partners
Sofinnova Partners investment in Series C - Hookipa Pharma
BioMedPartners
BioMedPartners investment in Series C - Hookipa Pharma
Sirona Capital
Sirona Capital investment in Series C - Hookipa Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-21 | HOOKIPA Announces Executive Leadership Changes |
| 2022-05-02 | HOOKIPA announces promotion of Christine D. Baker to Chief Operating Officer |
| 2022-03-22 | HOOKIPA Announces Promotion of Klaus Orlinger, Ph.D. to Chief Scientific Officer |
Official Site Inspections
http://www.hookipapharma.com Semrush global rank: 4.96 M Semrush visits lastest month: 1.72 K
- Host name: hookipa-web1.customers.nextlayer.at
- IP address: 217.175.202.148
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna
More informations about "Hookipa Pharma"
Investor Relations | Hookipa Pharma Inc.
Jan 7, 2025 NEW YORK and VIENNA, Austria, Jan. 07, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage biopharmaceutical company developing next …See details»
Executives - Hookipa Pharma
The Empire State Building 350 Fifth Avenue, Room/Suite 7240 New York, NY 10118See details»
HOOKIPA Pharma Inc. - LinkedIn
At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage …See details»
HOOKIPA Pharma Appoints Mark Winderlich as Chief …
Jan 16, 2024 Find out more about HOOKIPA online at www.hookipapharma.com. ... HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research …See details»
News Releases - ir.hookipapharma.com
Jan 30, 2025 Find out more about HOOKIPA online at www.hookipapharma.com. Forward Looking Statements Certain statements set forth in this press release constitute “forward …See details»
Hookipa Pharma - Crunchbase Company Profile
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms.See details»
Hookipa Pharma Careersite
Careers. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus …See details»
Company Overview - Hookipa Pharma
The Empire State Building 350 Fifth Avenue, Room/Suite 7240 New York, NY 10118See details»
Board of Directors - Hookipa Pharma
Julie O´Neill Julie O’Neill is Non-Executive Chair of the Board of Directors of HOOKIPA. A business professional with more than two decades of executive experience in senior leadership roles, Ms. O’Neill was formerly Executive Vice …See details»
HOOKIPA Pharma Inc. Information - RocketReach
At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage …See details»
HOOKIPA Pharma Inc. - Vienna BioCenter
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which are …See details»
HOOKIPA Pharma Inc. Company Overview, Contact Details
To learn more please visit www.hookipapharma.com. Sign up for free to view info. Email Format Employee directory . Company Overview. Headquarters The Empire State Building 350 Fifth …See details»
HOOKIPA Pharma Provides Update on Business Priorities and …
Dec 31, 2023 HOOKIPA maintains a strong cash position of $117.5 million 1 as of December 31, 2023, and believes that the planned reductions will help to conserve resources and better align …See details»
Working At HOOKIPA Pharma: Company Overview and Culture
Mar 14, 2024 www.hookipapharma.com. Organization Type. Public. Social Media. Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious …See details»
HOOKIPA Pharma Provides Update on Business Priorities and …
Jan 29, 2024 HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious disease HOOKIPA will …See details»
HOOKIPA Announces Executive Leadership Change
Sep 13, 2023 Find out more about HOOKIPA online at www.hookipapharma.com. Forward Looking Statements. Certain statements set forth in this press release constitute “forward …See details»
Our Culture - Hookipa Pharma
The Empire State Building 350 Fifth Avenue, Room/Suite 7240 New York, NY 10118See details»
Poolbeg Pharma plc and HOOKIPA Pharma Inc. Provide Update on …
Jan 10, 2025 IR@hookipapharma.com Chuck@LifeSciAdvisors.com: Moelis & Company (Financial Adviser to HOOKIPA) +44 (0) 207 634 3500: London Chris Raff Simon Chaudhuri …See details»
HOOKIPA Pharma Provides Update on Business Priorities and
Jan 29, 2024 HOOKIPA maintains a strong cash position of $117.5 million 1 as of December 31, 2023, and believes that the planned reductions will help to conserve resources and better align …See details»
Exploring bacopa: the science behind the latest brain health trend
Jan 31, 2025 Disclosure statement. James Goodwin does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has …See details»